TX-SOFTSERVE
30.8.2022 13:06:40 CEST | Business Wire | Press release
SoftServe, a leading digital authority and consulting company, has released the company’s sustainability report for 2021. Prepared in accordance with GRI standards, the report highlights SoftServe’s commitment to sustainability practices as a dedicated member of the United Nations Global Compact. The report provides an overview of the company’s corporate social responsibility (CSR) initiatives, including governance of CSR, IT education, environmental management, and progress in diversity, equity, and inclusion (DE&I).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220830005028/en/
Report demonstrates the company’s commitment to sustainability practices and obligations as a member of the United Nations Global Compact. (Photo: Business Wire)
“SoftServe’s mission is to empower talented people to change the world,” said Chris Baker, CEO. “We stay committed to that mission by making our clients successful, developing our teams and ourselves while innovating every day. This Sustainability Report reflects our ongoing commitment to bringing a sustainable future to our clients, associates, and communities.”
Governance of CSR
SoftServe maintains five cross-functional sustainability councils overseeing individual CSR initiatives. Each council consists of contributors from specific business groups and is overseen by a chairperson and an executive sponsor to ensure effective decision-making processes. As many as 70 leaders throughout the organization are engaged in councils and contribute their efforts to building sustainable practices and scaling impact across the business.
IT Education
IT education and training for qualified specialists remains one of the key areas of corporate social responsibility of the company. SoftServe collaborates with 64 universities around the world, and in 2021 alone, introduced four undergraduate programs with a dual form of education combining theoretical classes with corporate practice.
SoftServe University, which celebrated its 15th anniversary last year, is developing a variety of solutions for both in-house training and for those looking to start an IT career. Out of 2,282 SoftServe IT Academy interns in 2021, most secured a new career with SoftServe - 120% more than a year earlier.
Environment
Last year, SoftServe reduced the number of direct emissions from the production of goods by 55.4% compared to the previous year. The company also introduced a new approach to environmental management and set ambitious environmental goals by 2031. These goals include becoming a zero-carbon business, achieving zero waste, designing environmentally sustainable offices, and developing IT solutions to help meet environmental challenges.
Diversity, Equity, and Inclusion
Principles of diversity, equity, and inclusion drive a culture at SoftServe where every associate has the same opportunity for growth and advancement. The company’s special Diversity, Equity & Inclusion Council works to adhere to these principles and promotes constant progress through operational action.
In addition, SoftServe is a globally responsible employer striving to make each associate’s learning journey as inclusive as possible. Over the last two years, and throughout rapid corporate expansion, SoftServe prioritized accessible office construction and inclusive learning design, and a recent accessibility audit shows an 18% increase in entirely accessible offices.
Click here for more information on SoftServe’s sustainability report.
About SoftServe
SoftServe is a digital authority that advises and provides at the cutting-edge of technology. We reveal, transform, accelerate, and optimize how enterprises and software companies do business. Our end-to-end solutions and expertise deliver innovation, quality, and speed across the healthcare, retail, energy, manufacturing, and financial services verticals. We empower enterprises and software companies to (re)identify differentiation, accelerate solution development, and vigorously compete in today’s marketplace—no matter where you are in your journey.
Visit our website, blog, LinkedIn, Facebook, and Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220830005028/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
EZVIZ’s Smart Entry Solutions Have Consecutively Clinched the European Product Design Award and the Golden Pin Design Award, Indicating a Shift From Home Security to Living Enjoyment23.10.2026 11:58:00 CEST | Press release
EZVIZ’s smart lock and AI-powered doorbell remained in the spotlight after IFA for bagging two world-class awards. The EP8 Ultra AI-powered video doorbell won the European Product Design Award 2026 (EPDA 2026), keeping leading in user-centric AI. Meanwhile, the DL50FVX smart lock was named the 2026 Golden Pin Design Award (GPDA) laureate for its intuitive access management and entered the finalist of the Best Design Awards. The growing prestige of EZVIZ’s smart home access management lineup marks a new chapter of providing living experiences with multi-level interaction, modern aesthetics, and emotional care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022441786/en/ Two representative models from EZVIZ's smart entry family take home prestigious awards for user-centric innovation. Founded in 2016, the EPDA aims to recognize well-thought-out products that break with tradition and improve everyday life. Continually refres
Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines23.10.2026 07:00:00 CEST | Press release
The Chinese National Medical Products Administration (NMPA) has approved Relfydess™, the first and only ready-to-use liquid neuromodulator designed with PEARL™ Technology, for the temporary improvement of moderate-to-severe glabellar lines (frown lines) in adults1,2 The approval is based on phase III results from a local clinical trial conducted in China as well as global READY clinical trials, with local results reinforcing that Relfydess delivers significant improvements in frown lines, with a fast onset of action as early as day one, and sustained results for up to six months in some patients3-7 This approval underscores Galderma’s continued leadership in the Asia-Pacific region and further expands the global reach of Relfydess, which is already authorized in more than 35 markets worldwide Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the
Andersen Consulting får ny samarbejdspartner i Usbekistan22.10.2026 21:34:00 CEST | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for cybersikkerhed og forretningstransformation gennem en samarbejdsaftale med Algoruni, et konsulentfirma med base i Usbekistan. Algoruni rådgiver organisationer om at opbygge cyberrobusthed og håndtere bredere prioriteter inden for ledelse, regulering og bæredygtighed. Virksomheden har base i Tasjkent og tilbyder tjenester inden for cybersikkerhedsstrategi og databeskyttelse, virksomhedsledelse og driftsforbedringer samt ESG-strategi og -rapportering. Fokus er på praktiske løsninger, der er tilpasset den enkelte kundes situation. "Enhver organisation står over for en unik kombination af risici og muligheder. Derfor mener vi, at effektive løsninger skal tage udgangspunkt i virksomhedens konkrete situation," udtalte Alisher Zaynutdinov, administrerende direktør for Algoruni. "Som samarbejdsvirksomhed med Andersen Consulting kan vi kombinere denne tilgang med et bredere netværk af internationale ressourcer og perspektiver, så vi får nye
Andersen Global udvider sine juridiske kompetencer i Argentina gennem samarbejde med MHR22.10.2026 20:20:00 CEST | Pressemeddelelse
Andersen Global styrker sine juridiske kompetencer i Argentina gennem en samarbejdsaftale med Martínez de Hoz & Rueda (MHR) efter integrationen af teamet fra MBP Partners i firmaet. MBP Partners var tidligere et samarbejdsfirma i Andersen Global og arbejdede sammen med organisationens medlemsfirmaer og samarbejdsfirmaer for at bistå klienter med både lokale og internationale forhold. Med integrationen af MBP Partners viderefører den nye samarbejdsaftale mellem Andersen Global og MHR det eksisterende samarbejde og styrker samtidig Andersen Globals juridiske kompetencer i Argentina. MHR er et fullservice advokatfirma, der rådgiver klienter inden for olie og gas, selskabsretlige og finansielle forhold, energi, minedrift, fintech, infrastruktur, teknologi og andre centrale sektorer. Firmaet bistår danske og internationale virksomheder, finansielle institutioner, investeringsfonde, fintechvirksomheder og andre organisationer med komplekse transaktioner, regulatoriske spørgsmål og strategisk
Mundipharma Announces Further Phase III ReSPECT Results Presented as a Late-Breaking Oral Presentation at IDWeek 202622.10.2026 19:03:00 CEST | Press release
For Trade and Medical Media Only Today Mundipharma announced additional results from the global Phase III ReSPECT clinical trial evaluating REZZAYO®(rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT). The Phase III findings were presented today as a late-breaking oral presentation at IDWeek 2026. The presentation provides additional detail following the top line ReSPECT results announced in April 2026, including further endpoint analyses, the components contributing to fungal-free survival (FFS), pre-specified sensitivity analyses and detailed safety outcomes. The additional analyses were consistent with the previously announced topline findings. ReSPECT was a global, multicentre, randomised, double-blind Phase III study in which 402 patients were randomised to rezafungin and 200 to the standard antimicrobial regimen. As previously announced, the study met its primary endpoi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
